Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)
Condition(s):HypertriglyceridemiaLast Updated:April 25, 2022Completed
Hide Studies Not Open or Pending
Condition(s):HypertriglyceridemiaLast Updated:April 25, 2022Completed
Condition(s):Renal Artery Obstruction; Kidney FailureLast Updated:April 27, 2006Completed
Condition(s):Ischemic Stroke; Large-Artery Atherosclerosis (Embolus/Thrombosis)Last Updated:November 1, 2022Recruiting
Condition(s):Heart Failure; Atrial Fibrillation; Healthy Ageing; HypercholesterolemiaLast Updated:September 3, 2020Unknown status
Condition(s):Familial HypercholesterolemiaLast Updated:October 13, 2022Recruiting
Condition(s):HypercholesterolemiaLast Updated:August 4, 2016Completed
Condition(s):Delirium; Anesthesia; Adverse EffectLast Updated:May 30, 2019Completed
Condition(s):Arthritis, RheumatoidLast Updated:June 2, 2021Completed
Condition(s):Rheumatoid ArthritisLast Updated:October 22, 2019Completed
Condition(s):Scleroderma, Systemic; Sclerosis, SystemicLast Updated:August 6, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.